Oxford-AstraZeneca vaccine behind lower Covid deaths in UK, says expert
'If you look across Europe, with the rise in cases, there's also a corresponding lagged rise in deaths, but not in the UK,' says Dr Clive Dix, former chairman of the UK's Vaccine Task Force
AstraZeneca's vaccine, dumped by the West, helps fill gaping need in rest of world
The Covid-19 shot, beset by early production problems and rare side effects, has been a workhorse for lower-income countries
AstraZeneca booster vaccines increases antibodies against Omicron: Study
After the booster shot, antibody levels against Omicron were higher than antibodies in people who are infected with and recovered naturally from Covid-19
Covid: Case data, vaccine news mark small victories in Omicron battle
AstraZeneca, Novavax say their shots protect from Omicron * UK data suggests fewer hospitalisations than from Delta ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the request for loss of share certificate from the claimant as per the attachment.
AstraZeneca booster shot effective against Omicron: Oxford lab study
After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus's Delta variant after two doses
AstraZeneca Covid vaccine protection wanes after three months: Lancet study
The vaccine is known as Covishield in India ASTRAZENECA PHARMA INDIA LTD. - 506820 - Closure of Trading Window
This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Shares of the Company shall be closed from December 16, 2021 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the quarter ending December 31, 2021.
USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZeneca
The study was done independently by investigators at the US Food and Drug Administration (USFDA), Center for Biologics Evaluation and Research.
Israel to donate 1,000,000 Covid-19 vaccines to African nations
The Foreign Ministry said the AstraZeneca vaccines would be transferred in the coming weeks